Work

Is NO an endogenous antiatherogenic molecule?

Year: 1994

Type: article

Abstract: E ndothelium-derived relaxing factor is now known to be nitric oxide (NO) or NO bound to a carrier molecule, possibly in the form of a nitrosothiol or nitrosoheme.13 NO is derived from the metabolism of L-arginine by NO synthase, which is expressed by a number of cell types, including endothelial cells, neurons, macrophages, platelets, and vascular smooth muscle cells.4

Source: Arteriosclerosis and Thrombosis A Journal of Vascular Biology

DOI: 10.1161/01.atv.14.5.653

Authors: J P Cooke, P S Tsao

Language: English

Topic: Nitric Oxide and Endothelin Effects

Subfield: Physiology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Heart, Lung, and Blood Institute

Awards: G1554283139, G5037022112, G8079078492